Pages that link to "Q35032865"
Jump to navigation
Jump to search
The following pages link to Thymidylate synthase (TYMS) enhancer region genotype-directed phase II trial of oral capecitabine for 2nd line treatment of advanced pancreatic cancer (Q35032865):
Displaying 3 items.
- Systemic therapies for pancreatic cancer--the role of pharmacogenetics (Q27021716) (← links)
- Thymidylate synthase gene (TYMS) polymorphisms in sporadic and hereditary breast cancer (Q36541583) (← links)
- Nucleoside analogs: ready to enter the era of precision medicine? (Q38842938) (← links)